Find premium alternative energy reports - docstoc

DocStore » Research Reports » Alternative Energy

Per Page: 15 25 50

2...

McLaren Health Care Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

McLaren Health Care Corporation, (MHCC) is a healthcare service providing company, based in the US. The company provides home care, medical supplies and health insurance services. Its services include blood conservation, cancer services, diagnostic imaging, dialysis services, homecare, nutritional counseling, pain management, robotic surgery, endoscopy services and women’s services. MHCC offers services in the areas of behavioral health, cardiac, diabetes, intensive care, internal medicine, pathology, neurosciences, pediatrics, primary care, proton therapy, urology and many more. The company operates through its hospitals such as, Lapeer Regional Medical Center, McLaren Regional Medical Center, Mt. Clemens Regional Medical Center, Ingham Regional Orthopedic Hospital, Bay Regional Medical Center, Bay Special Care Hospital and POH Regional Medical Center. MHCC is headquartered in Flint in Michigan, the US.
China Development Industrial Bank - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

China Development Industrial Bank is engaged in investment banking in Taiwan. It also provides several banking and financial services to enterprises and institutions including lending, treasury transactions, project finance, and advisory and trust services.
Proteon Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Proteon Therapeutics, Inc. (Proteon) is a privately held biopharmaceutical company, based in the US. The company develops pharmaceuticals products for the treatment of renal and vascular diseases such as hemodialysis and peripheral arterial disease (PAD). It offers PRT-201, a recombinant human elastase that fragments elastin fibers in blood vessel walls. Proteon has developed clinical development programs for PRT-201 in two hemodialysis vascular access indications which include arteriovenous fistulas and arteriovenous grafts. The company own and operates research facilities in Kansas City, Missouri. It was incorporated in the year 2001. Proteon is headquartered in Waltham, Massachusetts, the US.
Affectis Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Affectis Pharmaceuticals AG, (Affectis) is a biopharmaceutical company, based in Germany. It develops novel drugs for the treatment of psychiatric and inflammatory disorders. The company’s products include cimicoxib, which is used for the treatment of depression and schizophrenia; AFC-5128, a P2X7 antagonist for the treatment of inflammatory diseases, such as rheumatoid arthritis; P2X7, a novel therapeutic for depression; AFC-5278 for the treatment of osteoporosis; and AF-08, which is for the treatment of depression. Affectis was formerly known as Neuronova AG and changed its name in January 2005. It has signed the licensing agreement with Merck Serono S.A. for the development and commercialization of oral compounds targeting P2X7 receptors. Affectis is headquartered in Martinsried, Germany.
InterMed Discovery GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

InterMed Discovery GmbH (InterMed Discovery) is a natural product lead discovery company based in Germany. It operates through its product segments, Pharmaceutical and food. The company develops innovative products for the life science, food and cosmetics industries. The company’s Pharmaceutical products include, IMD 026259, IMD 026260, IMD 021365, IMD 020102 and IMD 009425. The products of food include IMD-001158, IMD-009144, IMD-027060 and IMD-011321. The company provides services in the areas such as, pharmaceutical, crop science and food. About 1,000 bioactive natural products have been isolated de novoto purity and elucidated in structure through bioactivity-guided LEAD identification. InterMed Discovery is headquartered in Dortmund, Germany.
Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Altor BioScience Corporation (Altor) is a biopharmaceutical company, based in the US. The company discovers, develops and commercializes of immunotherapeutic drugs for the treatment of viral infections, cancer and autoimmune diseases. Altor offers reagents for the diagnosis and treatment of cancer and viral infections for the research and design of anti-viral and anti cancer vaccines. The company develops monoclonal antibody, which prevents and treats staphylococcal infections in premature neonates, has been licensed to Biosynexus. Its products are useful for the detection of peptide antigens present in diseases tissues and cells. The company was founded in the year 2002. Altor is headquartered in Miramar, Florida, the US.
Anchor Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Anchor Therapeutics, Inc. (Anchor) is a drug manufacturing company, based in the US. The company designs and develops peptide modulators of G protein-coupled receptors (GPCRs). It discovers and develops therapies for cancer, heart diseases, inflammatory diseases and pain. Anchor develops pepducin lipopeptide drug candidates, which are molecules that target the intracellular domains of G protein coupled receptors (GPCRs) to allosterically modulate GPCR signaling. The company’s pepducin technology platform is used to develop lipopeptide allosteric modulators for intractable GPCR targets. It was incorporated in the year 2006. Anchor is headquartered in Cambridge, Massachusetts, the US.
APT Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

APT Pharmaceuticals, Inc. (APT Pharmaceuticals) is a drug development company, based in the US. The company is involved in pulmonary delivery treatments for lung diseases. The company's lead product is inhaled cyclosporine for the prevention of chronic lung transplant rejection. The other products include inhaled anti-inflammatory agent used for troublesome inflammation in patients with cystic fibrosis, chronic obstructive pulmonary disease, and bronchiectasis and lung transplant. Inhaled immunomodulator is used for treating idiopathic pulmonary fibrosis and inhaled hydroxychloroquine (HCQ) for the treatment of allergic asthma. APT Pharmaceuticals strongly focuses on the research and development activities for the development of its product candidates for curing lung diseases. APT Pharmaceuticals is headquartered at Burlingame, California, the US.
Ocera Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Ocera Therapeutics, Inc. (Ocera) is a biopharmaceutical company, based in the US. The company operates through drug manufacturing and discovery. It develops, manufactures and commercializes novel therapeutics for liver and gastrointestinal diseases. The product of the company includes OCR-002 for the treatment of Acute Hepatic Encephalopathy (AHE) and AST-120 for curing unwanted substances in the digestive tract. The product pipeline addresses the therapeutic areas such as Mild Hepatic Encephalopathy, Acute Hepatic Encephalopathy in Liver Cirrhosis, Acute Hepatic Encephalopathy in Acute Liver Failure, Irritable Bowel Syndrome and Pouchitis. Moreover, Ocera partners with Kureha Corporation and University College London Business. Ocera is headquartered San Diego, California, the US.
Alligator Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Alligator Bioscience AB (Alligator Bioscience) is a pharmaceutical company, based in Sweden. It discovers and develops biopharmaceuticals. The company uses its proprietary protein optimization technology FIND (Fragment Induced Diversity), for the optimization of drugs. This technology is useful for redesigning of any protein characteristics for significant clinical benefits such as potency, efficacy, decreased immunogenicity and safety. Its drug candidates focus on the treatment of cancer and inflammatory diseases. Alligator Bioscience is building a competitive pipeline of novel and improved drug candidates in cancer and inflammation. It has entered into collaborative partnerships with various biotechnology and pharmaceutical companies including Bayer Schering, Astra Zeneca, ImmRx, HemoCue AB, Enzymes/Roal, AxisShield ASA, PolyTherics Ltd and Wyeth. Alligator Bioscience is headquartered in Lund, Sweden.
Celator Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Celator Pharmaceuticals, Inc. (Celator) is a pharmaceutical healthcare company, based in the US. The company develops therapies to treat cancer based on its CombiPlex technology platform. Its products include CPX-351 (cytarabine: daunorubicin), CPX-1 (irinotecan HCI: floxuridine), CPX-571 (irinotecan HCl: cisplatin), CPX-8XY and other preclinical programs. Celator’s proprietary drug technology platform, CombiPlex, has shown significant promise in identifying, delivering and maintaining synergistic ratios of chemotherapeutic drugs resulting in new drug product candidates. Its current research focus involves the use of drugs that are already approved and used widely to treat cancer. The company was incorporated in the year 2000. Celator is headquartered in Princeton, New Jersey, the US.
Indena S.p.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Indena S.p.A. (Indena) is a pharmaceutical company, based in Italy. The company identifies, develops and produces active principles derived from plants for pharmaceutical, health-food and cosmetics industries. It operates through product portfolio includes Pharmaceutical, Health-Food, Cosmetics, Phytosome and Flavours. Indena has entered into a licensing and co-development agreement with Zambon Company S.p.A. The company markets its products in France, the US China and Japan. It has granted a Certificate of Suitability of the European Pharmacopoeia (CEP) for two products which include bilberry fruit dry extract and Valerian dry hydroalcoholic extract. The company operates as a subsidiary of IdB Holding S.p.A. Indena is headquartered in Milan, Lombardy, Italy.
Aegera Therapeutics Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Aegera Therapeutics Inc. (Aegera) is a healthcare company, based in Canada. It develops targeted therapeutics to meet the medical needs. The company focuses on preclinical and early-stage clinical development through integration of in-house medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera pipeline has clinical programs and preclinical programs platforms. Its clinical programs platform include HGS1029 compound and preclinical programs has IAP inhibitors, tyrosine kinase inhibitors and HSP90 inhibitors compound. The company is partnered with Human Genome Sciences and Neurologix. It operates as a subsidiary of Pharmascience Inc. Aegera is headquartered in Montreal, Quebec, Canada.
Biolex Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Biolex Therapeutics, Inc. (Biolex) is a biopharmaceutical company, engaged in the development and commercialization of therapeutic proteins and monoclonal antibodies based on its proprietary LEX system. Biolex has developed LEX system, a novel technology that genetically transforms the aquatic plant lemna to enable the production of biologic product candidates. The strengths of LEX System includes production of complex proteins, complex protein folding, optimization of monoclonal antibodies, access to product candidates, reduced safety risk, reduced capital cost and facility timelines. Biolex' product pipeline includes locteron, a controlled release formulation of recombinant human alpha interferon developed for the treatment of hepatitis C; BLX-155, full-length recombinant plasmin (fibrinolysin) produced with the LEX System developed for the treatment of thrombosis and BLX-301, an anti-CD20 antibody incorporating the optimized glycosylation structure. Biolex Therapeutics, Inc. operates as a biopharmaceutical company. It offers Locteron, a controlled-release interferon Alfa for the treatment of hepatitis C; BLX-155, a thrombolytic or clot buster to dissolve blood clots; and BLX-301, an antibody for the treatment of B-cell lymphoma. Biolex Therapeutics, Inc. has a research and development collaboration with Merial Limited to produce veterinary vaccines. The company is headquartered at Pittsboro in North Carolina, the US.
BioPro Pharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

BioPro Pharmaceutical, Inc. (BioPro) is a pharmaceutical service provider, based in the US. The company develops, manufactures, and markets biopharmaceutical oncology medicines for cancer and related illness treatment. It provides Gliadel; Vantas, a drug-delivery system that contains the medicine histrelin, which helps to relieve the symptoms of prostate cancer; gliolan, fentanyl HPQ patch, temozolomide, adherus, fentanyl tab and permixon comprimidos. The company has entered into an agreement with Ceragenix Pharmaceuticals, Inc., for the distribution of epicerem, a prescription topical cream for treating atopic dermatitis and other dry skin conditions in Hong Kong and Taiwan regions. BioPro is headquartered in San Francisco, California, the US.

Per Page: 15 25 50

2...

Alternative Energy

Find premium alternative energy research reports. Purchase and download high quality report analysis, environmental reports, technology reports, alternative research reports, and much more

DocStore Search:

DocStore » Research Reports » Alternative Energy

McLaren Health Care Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

China Development Industrial Bank - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Proteon Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Affectis Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

InterMed Discovery GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Anchor Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

APT Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ocera Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alligator Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celator Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Indena S.p.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aegera Therapeutics Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biolex Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioPro Pharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile